Pharsight

Drug Patents Expiring in 2014

1. Abilify Maintena Kit patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US5006528 OTSUKA PHARM CO LTD Carbostyril derivatives
Oct, 2014

(9 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-746) Jul 27, 2020
New Dosage Form(NDF) Feb 28, 2016
M(M-150) Dec 05, 2017

Drugs and Companies using ARIPIPRAZOLE ingredient

Market Authorisation Date: 28 February, 2013

Treatment: Treatment of schizophrenia, with efficacy in treating acute episodes of schizophrenia

Dosage: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

How can I launch a generic of ABILIFY MAINTENA KIT before it's drug patent expiration?
More Information on Dosage

ABILIFY MAINTENA KIT family patents

Family Patents

2. Copaxone patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6362161 TEVA PHARMS USA Copolymer-1 improvements on compositions of copolymers
May, 2014

(9 years ago)

US7199098 TEVA PHARMS USA Copolymer-1 improvements in compositions of copolymers
May, 2014

(9 years ago)

US6054430 TEVA PHARMS USA Copolymer-1 improvements in compositions of copolymers
May, 2014

(9 years ago)

US8367605 TEVA PHARMS USA Copolymer-1 improvements in compositions of copolymers
May, 2014

(9 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Jan 28, 2017
New Indication(I-594) Feb 27, 2012

Drugs and Companies using GLATIRAMER ACETATE ingredient

Market Authorisation Date: 20 December, 1996

Treatment: NA

Dosage: INJECTABLE;SUBCUTANEOUS

How can I launch a generic of COPAXONE before it's drug patent expiration?
More Information on Dosage

COPAXONE family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Minivelle patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US5656286 NOVEN Solubility parameter based drug delivery system and method for altering drug saturation concentration
Aug, 2014

(9 years ago)

Drugs and Companies using ESTRADIOL ingredient

Market Authorisation Date: 23 September, 2014

Treatment: NA

Dosage: FILM, EXTENDED RELEASE;TRANSDERMAL

How can I launch a generic of MINIVELLE before it's drug patent expiration?
More Information on Dosage

MINIVELLE family patents

Family Patents

4. Nexium 24hr patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6875872 ASTRAZENECA LP Compounds
May, 2014

(9 years ago)

Drug Exclusivity Drug Exclusivity Expiration
RTO(RTO) Mar 28, 2017

Drugs and Companies using ESOMEPRAZOLE MAGNESIUM ingredient

Market Authorisation Date: 28 March, 2014

Treatment: NA

Dosage: CAPSULE, DELAYED RELEASE;ORAL

How can I launch a generic of NEXIUM 24HR before it's drug patent expiration?
More Information on Dosage

NEXIUM 24HR family patents

Family Patents

5. Novolog Flextouch patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US5618913 NOVO NORDISK INC Insulin analogues
Jun, 2014

(9 years ago)

Drugs and Companies using INSULIN ASPART RECOMBINANT ingredient

Market Authorisation Date: 31 October, 2013

Treatment: NA

Dosage: INJECTABLE;SUBCUTANEOUS

More Information on Dosage

NOVOLOG FLEXTOUCH family patents

Family Patents

6. Noxafil patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US5703079 MERCK SHARP DOHME Tetrahydrofuran antifungals
Aug, 2014

(9 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population(NPP) May 31, 2024
Orphan Drug Exclusivity(ODE-355) Jun 17, 2028
New Indication(I-881) Jun 17, 2024

Drugs and Companies using POSACONAZOLE ingredient

Market Authorisation Date: 25 November, 2013

Treatment: Prophylaxis of invasive aspergillus and candida infections

Dosage: TABLET, DELAYED RELEASE;ORAL; SOLUTION;INTRAVENOUS

How can I launch a generic of NOXAFIL before it's drug patent expiration?
More Information on Dosage

NOXAFIL family patents

Family Patents

7. Varithena patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
USRE38919 PROVENSIS Injectable microfoam containing a sclerosing agent
Oct, 2014

(9 years ago)

Drugs and Companies using POLIDOCANOL ingredient

Market Authorisation Date: 21 December, 2017

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

VARITHENA family patents

Family Patents